Bafna Pharmaceuticals Limited BAFNAPH.NS Stock
Bafna Pharmaceuticals Limited Price Chart
Bafna Pharmaceuticals Limited BAFNAPH.NS Financial and Trading Overview
| Bafna Pharmaceuticals Limited stock price | 87 INR |
| Previous Close | 118.25 INR |
| Open | 118.25 INR |
| Bid | 0 INR x N/A |
| Ask | 0 INR x N/A |
| Day's Range | 118.25 - 118.25 INR |
| 52 Week Range | 77.05 - 124.95 INR |
| Volume | 1.04K INR |
| Avg. Volume | 1.48K INR |
| Market Cap | 2.82B INR |
| Beta (5Y Monthly) | 0.820196 |
| PE Ratio (TTM) | 24.331276 |
| EPS (TTM) | 4.78 INR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | September 19, 2013 |
| 1y Target Est | N/A |
BAFNAPH.NS Valuation Measures
| Enterprise Value | 2.87B INR |
| Trailing P/E | 24.331276 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.4466443 |
| Price/Book (mrq) | 3.695659 |
| Enterprise Value/Revenue | 2.49 |
| Enterprise Value/EBITDA | 18.278 |
Trading Information
Bafna Pharmaceuticals Limited Stock Price History
| Beta (5Y Monthly) | 0.820196 |
| 52-Week Change | 1.19% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 124.95 INR |
| 52 Week Low | 77.05 INR |
| 50-Day Moving Average | 94.19 INR |
| 200-Day Moving Average | 98.03 INR |
BAFNAPH.NS Share Statistics
| Avg. Volume (3 month) | 1.48K INR |
| Avg. Daily Volume (10-Days) | 1.48K INR |
| Shares Outstanding | 23.66M |
| Float | 1.68M |
| Short Ratio | N/A |
| % Held by Insiders | 91.34% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 9.82% |
| Operating Margin (ttm) | 9.00% |
| Gross Margin | 33.59% |
| EBITDA Margin | 13.62% |
Management Effectiveness
| Return on Assets (ttm) | 5.90% |
| Return on Equity (ttm) | 16.63% |
Income Statement
| Revenue (ttm) | 1.15B INR |
| Revenue Per Share (ttm) | 49.44 INR |
| Quarterly Revenue Growth (yoy) | 182.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | 157.16M INR |
| Net Income Avi to Common (ttm) | 113.38M INR |
| Diluted EPS (ttm) | 4.86 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 78.1M INR |
| Total Cash Per Share (mrq) | 3.4 INR |
| Total Debt (mrq) | 236.01M INR |
| Total Debt/Equity (mrq) | 32.13 INR |
| Current Ratio (mrq) | 1.879 |
| Book Value Per Share (mrq) | 31.997 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 49.53M INR |
| Levered Free Cash Flow (ttm) | -91986496 INR |
Profile of Bafna Pharmaceuticals Limited
| Country | India |
| State | N/A |
| City | Chennai |
| Address | Bafna Towers |
| ZIP | 600001 |
| Phone | 91 44 4267 7555 |
| Website | https://www.bafnapharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets. It also exports its products. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India.
Q&A For Bafna Pharmaceuticals Limited Stock
What is a current BAFNAPH.NS stock price?
Bafna Pharmaceuticals Limited BAFNAPH.NS stock price today per share is 87 INR.
How to purchase Bafna Pharmaceuticals Limited stock?
You can buy BAFNAPH.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bafna Pharmaceuticals Limited?
The stock symbol or ticker of Bafna Pharmaceuticals Limited is BAFNAPH.NS.
Which industry does the Bafna Pharmaceuticals Limited company belong to?
The Bafna Pharmaceuticals Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Bafna Pharmaceuticals Limited have in circulation?
The max supply of Bafna Pharmaceuticals Limited shares is 23.84M.
What is Bafna Pharmaceuticals Limited Price to Earnings Ratio (PE Ratio)?
Bafna Pharmaceuticals Limited PE Ratio is 18.20083600 now.
What was Bafna Pharmaceuticals Limited earnings per share over the trailing 12 months (TTM)?
Bafna Pharmaceuticals Limited EPS is 4.78 INR over the trailing 12 months.
Which sector does the Bafna Pharmaceuticals Limited company belong to?
The Bafna Pharmaceuticals Limited sector is Healthcare.